News | August 04, 2008

New GE CT Scanner Technology Captures Rodent Heart Beat at 600 Beats-Per-Minute

August 5, 2008 - GE Healthcare today released a new pre-clinical computed tomography scanner specifically designed to accelerate research in the areas of cardiac disease and drug development.

The GE eXplore CT 120 scanner is an all-new design based on years of research CT scanner experience, GE officials said. Using X-ray source technology derived from clinical systems, the eXplore CT 120 features 100 times the output of previous GE laboratory research imaging systems. This power enables X-ray exposures fast enough and detailed enough to capture the motion of a beating mouse heart, and brings the power of cardiac CT imaging to a popular mammal used in disease research and drug development.

The power of the new X-ray source also allows for more effective filtering of the X-ray beam, reducing the X-ray dose to the research subject compared to previous scanners, while greatly reducing the scan time.

“Morphological imaging is the key to understanding cardiac kinetics,” said Professor André Constantinesco of Hôpitaux Universitaires de Strasbourg. “This scanner provides us the ability to acquire 4D, high-resolution datasets in living mice, improving our ability to quantify rodent models of cardiac diseases.”

The scanner’s user software is designed for throughput and, with its powerful computing hardware, makes the scanner four times faster than previous designs. Industry-standard DICOM compatibility and an optional analysis workstation assist in timely image analysis and production of research data.

For more information: www.gehealthcare.com


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now